Skip to search formSkip to main contentSkip to account menu

safingol

Known as: L-threo-2-Amino-1,3-octadecanediol, 2-aminooctadecane-1,3-diol, (2S,3S)-2-Amino-1,3-Octadecanediol 
A saturated derivative of sphingosine. As an inhibitor of protein kinase C (PKC), safingol competitively binds to the regulatory phorbol-binding… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Fundamental Research Funds for the Central Universities [2010121014]; Natural Science Foundation of Fujian Province [2013J10011] 
2009
2009
Colon cancer represents one of the most common solid tumors in adults. Although 5-fluorouracil (5-FU) and irinotecan have been… 
2009
2009
The protein kinase C (PKC) inhibitor safingol increased rounding and detachment of human oral squamous cell carcinoma (SCC) cells… 
2006
2006
PKC inhibitor safingol suppressed the growth of human oral squamous cell carcinoma (SCC) cells significantly at concentrations… 
2002
2002
Protein kinase C (PKC) plays a pivotal role in signal transduction involved in the control of cell proliferation, differentiation… 
Review
2001
Review
2001
PKC isoenzymes were found to be involved in proliferation, antitumor drug resistance and apoptosis. Therefore, it has been tried… 
Highly Cited
2000
Highly Cited
2000
Purpose: Cyclooxygenase-2 (COX-2) is involved in antiapoptosis signaling, and its induction may require activation of protein… 
Highly Cited
1995
Highly Cited
1995
Safingol is a lysosphingolipid protein kinase C (PKC) inhibitor that competitively interacts at the regulatory phorbol binding…